
HCL Technologies Gears Up for Q3 Reveal on 13th January; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 12 Jan 2026 • 6:07 pm
Posted by:

HCL Technologies, one of the most significant Indian conglomerates, is set to announce its Q3 results for FY26 on 13th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
HCL Technologies Q3 Results 2026 Preview
- HCL Technologies’ revenue is expected to be in the range of ₹31,942 crore, up 10.7% YoY.
- Profit After Tax, or PAT, is projected to rise by 10% YoY.
- HCL Technologies’ EBITDA is expected to rise to ₹7,000 crore.
- Net profit at ₹4,082 crore, up by 25% YoY
HCL Technologies Share Performance
- Over the past six months, HCL Technologies’ share price has risen by 2.91% to ₹1,667.
- Moreover, over the past year, the stock has decreased by 16.21%.
- Despite this weak short-term performance, HCL Technologies’ stock has delivered a financially sound 68.42% return over the past 5 years.
- As of 12th January 2026, the stock traded at ₹1,667 per share.
Key Factors to Watch for HCL Technologies
- Revenue and Margin Guidance: Management’s commentary and updates to annual revenue and EBIT margin guidance are closely monitored for insights into the company’s outlook.
- Segment Performance: The performance of key business segments, particularly the seasonally strong Products and Platforms (P&P) and Engineering and R&D (ER&D) services, is are key revenue driver.
- Profitability and Margins: Factors such as wage hikes, restructuring costs, operational efficiencies, and currency movements can impact the company’s operating and net profit margins.
Final Thoughts
HCL Technologies will announce its Q3 FY26 results on 13th January 2026. Analysts expect strong revenue growth of up to 10.7% YoY, a 10% rise in PAT, and a 65% rise in EBITDA. HCL Technologies primarily focuses on providing a comprehensive range of IT and business services, engineering and R&D services and modernised software products.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Taurian MPS IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Accelerator IPO GMP & Review: Apply or Avoid?
Recent Articles

Stock Market Predictions for Tomorrow 1 June 2026: Nifty Outlook, Key Levels and Analyst Views
31 May 2026

Weekly Update- 30th May 2026
30 May 2026

Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
29 May 2026

Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
29 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stock Market Predictions for Tomorrow 1 June 2026: Nifty Outlook, Key Levels and Analyst Views
Weekly Update- 30th May 2026
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
Popular this week
Stock Market Predictions for Tomorrow 1 June 2026: Nifty Outlook, Key Levels and Analyst Views
Weekly Update- 30th May 2026
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





